{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:13:37Z","timestamp":1778037217009,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10067-022-06462-y","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T11:02:59Z","timestamp":1670842979000},"page":"1137-1150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities"],"prefix":"10.1007","volume":"42","author":[{"given":"Shenglong","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-5860","authenticated-orcid":false,"given":"Yongqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"issue":"07","key":"6462_CR1","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1055\/a-1230-0002","volume":"80","author":"D Deharde","year":"2020","unstructured":"Deharde D, Klockenbusch W, Schmitz R et al (2020) Correction: Hydroxychloroquine as a preventive and therapeutic option in preeclampsia-a literature review[J]. Geburtshilfe Frauenheilkd 80(07):e71\u2013e71","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"6462_CR2","first-page":"6","volume":"48","author":"J Li","year":"2021","unstructured":"Li J, Polonium Chen BN, Zhang LY et al (2021) The use and research progress of hydroxychloroquine in improving placenta-derived pregnancy complications[J]. Intl J Obstet Gynecol 48(3):6","journal-title":"Intl J Obstet Gynecol"},{"key":"6462_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.09.002","volume":"64","author":"M Petri","year":"2020","unstructured":"Petri M (2020) Pregnancy and systemic lupus erythematosus [J]. Best Pract Res Clin Obstet Gynaecol 64:24\u201330","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"6462_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias G, Agmonlevin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning assisted reproduction pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome [J]. Ann Rheum Dis 76(3):476\u2013485","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6462_CR5","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0049-3848(19)30366-4","volume":"181","author":"K Schreiber","year":"2019","unstructured":"Schreiber K, Hunt BJ (2019) Managing antiphospholipid syndrome in pregnancy. Thromb Res 181(1):S41\u2013S46","journal-title":"Thromb Res"},{"issue":"8","key":"6462_CR6","first-page":"6","volume":"23","author":"Chinese Medical Association, Perinatal Medicine Branch","year":"2020","unstructured":"Chinese Medical Association, Perinatal Medicine Branch (2020) Expert consensus on the diagnosis and management of obstetric antiphospholipid syndrome[J]. Chin J Perinatal Med 23(8):6","journal-title":"Chin J Perinatal Med"},{"key":"6462_CR7","doi-asserted-by":"crossref","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017). 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome [J]. Ann Rheum Dis  76(1):9\u201316","DOI":"10.1136\/annrheumdis-2016-210571"},{"key":"6462_CR8","doi-asserted-by":"crossref","unstructured":"Levy RA, GR De Jes\u00fas, NR De Jes\u00fas et al (2016) Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation[J]. Autoimmun Rev 15(10):955\u2013963","DOI":"10.1016\/j.autrev.2016.07.014"},{"issue":"9","key":"6462_CR9","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/art.27580","volume":"62","author":"T Neogi","year":"2010","unstructured":"Neogi T, Aletaha D, Silman AJ et al (2010) The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report[J]. Arthritis Rheumatol 62(9):2582\u20132591","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"6462_CR10","doi-asserted-by":"publisher","first-page":"e12762","DOI":"10.1111\/aji.12762","volume":"78","author":"A Spinillo","year":"2017","unstructured":"Spinillo A, Beneventi F, Caporali R et al (2017) Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association?[J]. Am J Reprod Immunol 78(6):e12762","journal-title":"Am J Reprod Immunol"},{"issue":"7","key":"6462_CR11","first-page":"8","volume":"40","author":"Chinese Expert Consensus on the Use of Immunosuppressive Drugs in Recurrent Miscarriage Combined with Rheumatic Immune Diseases","year":"2020","unstructured":"Chinese Expert Consensus on the Use of Immunosuppressive Drugs in Recurrent Miscarriage Combined with Rheumatic Immune Diseases (2020) Chinese Expert Consensus on the Use of Immunosuppressive Drugs in Recurrent Abortion Combined with Rheumatic Diseases[J]. Chin J Reprod Contracept 40(7):8","journal-title":"Chin J Reprod Contracept"},{"issue":"11","key":"6462_CR12","first-page":"6","volume":"36","author":"HY Wang","year":"2020","unstructured":"Wang HY (2020) Recurrent miscarriage and autoimmune diseases[J]. Chin J Pract Gynecol Obstet 36(11):6","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"001","key":"6462_CR13","first-page":"3","volume":"000","author":"Obstetrics and Gynecology Section of the Chinese Medical Association","year":"2016","unstructured":"Obstetrics and Gynecology Section of the Chinese Medical Association (2016) Expert consensus on the diagnosis and management of recurrent miscarriage[J]. Chin J Obstet Gynecol 000(001):3\u20139","journal-title":"Chin J Obstet Gynecol"},{"key":"6462_CR14","doi-asserted-by":"crossref","unstructured":"Rpl TEGGO, Ruth BA, Bjarne CO etal (2018) ESHRE guideline: recurrent pregnancy loss[J]. Hum Reprod Open 2018(2):hoy004","DOI":"10.1093\/hropen\/hoy004"},{"issue":"6","key":"6462_CR15","first-page":"20","volume":"22","author":"Fetal Medicine Group of the Perinatal Medicine Branch of the Chinese Medical Association Obstetrics and Gynecology Section of the Chinese Medical Association","year":"2019","unstructured":"Fetal Medicine Group of the Perinatal Medicine Branch of the Chinese Medical Association Obstetrics and Gynecology Section of the Chinese Medical Association (2019) Expert consensus on fetal growth restriction (2019 edition) [J]. Chin J Perinatal Med 22(6):20","journal-title":"Chin J Perinatal Med"},{"issue":"4","key":"6462_CR16","first-page":"227","volume":"55","author":"Z Yang","year":"2020","unstructured":"Yang Z, Zhang WY (2020) Guidelines for the diagnosis and management of hypertensive disorders in pregnancy (2020)[J]. Chin J Obstet Gynecol 55(4):227\u2013238","journal-title":"Chin J Obstet Gynecol"},{"issue":"3","key":"6462_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1055\/a-1184-8388","volume":"40","author":"L Skeith","year":"2020","unstructured":"Skeith L, Blondon M, Inle FN (2020) Understanding and preventing placenta-mediated pregnancy complications[J]. Hamostaseologie 40(3):356\u2013363","journal-title":"Hamostaseologie"},{"key":"6462_CR18","doi-asserted-by":"crossref","unstructured":"Albrecht ED, Pepe GJ (2020) Regulation of uterine spiral artery Remodeling: a Review[J]. Reprod Sci 27(10):1932\u20131942","DOI":"10.1007\/s43032-020-00212-8"},{"issue":"8","key":"6462_CR19","first-page":"8","volume":"59","author":"Q Zeng","year":"2021","unstructured":"Zeng Q, Tingting W (2021) Research progress of maternal-fetal immune regulation mechanism[J]. J Shandong Univ: Med Ed 59(8):8","journal-title":"J Shandong Univ: Med Ed"},{"key":"6462_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2014.00244","volume":"5","author":"A Perez-Sepulveda","year":"2014","unstructured":"Perez-Sepulveda A, Torres MJ, Khoury M et al (2014) Innate immune system and preeclampsia [J]. Front Immunol 5:244","journal-title":"Front Immunol"},{"key":"6462_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biopha.2017.01.016","volume":"88","author":"M Ghaebi","year":"2017","unstructured":"Ghaebi M, Nouri M, Ghasemzadeh A et al (2017) Immune regulatory network in successful pregnancy and reproductive failures [J]. Biomed Pharmacother 88:61\u201373","journal-title":"Biomed Pharmacother"},{"key":"6462_CR22","doi-asserted-by":"crossref","unstructured":"Somers EC (2020) Pregnancy And Autoimmune Diseases[J]. Best Pract Res Clin Obstet Gynaecol 64:3\u201310","DOI":"10.1016\/j.bpobgyn.2019.11.004"},{"key":"6462_CR23","doi-asserted-by":"crossref","unstructured":"Beksac MS, HG Dnmez (2020) Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug[J]. J Obstet Gynaecol Res 47(2)","DOI":"10.1111\/jog.14561"},{"issue":"4","key":"6462_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.preghy.2016.09.001","volume":"6","author":"R Rahman","year":"2016","unstructured":"Rahman R, Murthi P, Singh H et al (2016) The effects of hydroxychloroquine on endothelial dysfunction[J]. Pregnancy Hypertens: an Intl J Women\u2019s Cardiovasc Health 6(4):259\u2013262","journal-title":"Pregnancy Hypertens: an Intl J Women's Cardiovasc Health"},{"key":"6462_CR25","doi-asserted-by":"crossref","unstructured":"Moreuil CD, Alavi Z, Pasquier E (2020) Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage[J]. Bri J Clin Pharmacol 86(1):39\u201349","DOI":"10.1111\/bcp.14131"},{"key":"6462_CR26","doi-asserted-by":"crossref","unstructured":"Rahman RA, Dekoninck P, Murthi P et al (2017) Treatment of preeclampsia with hydroxychloroquine: a review [J]. J Matern Fetal Neonatal Med 31(4):525\u2013529","DOI":"10.1080\/14767058.2017.1289511"},{"key":"6462_CR27","unstructured":"KOU Xi, ZHAO Ai-Min (2021) Research progress of hydroxychloroquine in the field of reproductive immunity[J]. J Shanghai Jiaotong Univ: Med Ed 41(003):380\u2013385"},{"issue":"2","key":"6462_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/aji.12184","volume":"71","author":"CR Albert","year":"2013","unstructured":"Albert CR, Schlesinger WJ, Viall CA et al (2013) Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function[J]. Am J Reprod Immunol 71(2):154\u2013164","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"6462_CR29","doi-asserted-by":"publisher","first-page":"103304","DOI":"10.1016\/j.jri.2021.103304","volume":"145","author":"A Spinillo","year":"2021","unstructured":"Spinillo A, Bellingeri C, Maggio ID et al (2021) The impact of various entities of anti-phospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective[J]. J Reprod Immunol 145(5):103304","journal-title":"J Reprod Immunol"},{"issue":"12","key":"6462_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4103\/0366-6999.207471","volume":"130","author":"SL Ye","year":"2017","unstructured":"Ye SL, Gu XK, Tao LY et al (2017) Efficacy of different treatment regimens for antiphospholipid syndrome-related recurrent spontaneous abortion [J]. Chin Med J 130(12):1395\u20131399","journal-title":"Chin Med J"},{"issue":"2","key":"6462_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","volume":"4","author":"N Costedoat-Chalumeau","year":"2005","unstructured":"Costedoat-Chalumeau N, Amoura Z, Du L et al (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature [J]. Autoimmun Rev 4(2):111\u2013115","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6462_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aji.12493","volume":"76","author":"A Mekinian","year":"2016","unstructured":"Mekinian A, Cohen J, Alijotas-Reig J et al (2016) Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation? [J]. Am J Reprod Immunol 76(1):8\u201328","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"6462_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2009","unstructured":"Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P et al (2009) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review[J]. Ann Rheum Dis 69(1):20\u201328","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"6462_CR34","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/acr.23808","volume":"71","author":"R Gaffar","year":"2019","unstructured":"Gaffar R, Pineau CA, Bernatsky S et al (2019) Risk of ocular anomalies in children exposed in utero to antimalarials: a systematic literature review[J]. Arthritis Care Res 71(12):1606\u20131610","journal-title":"Arthritis Care Res"},{"issue":"5","key":"6462_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bcp.12872","volume":"81","author":"YC Kaplan","year":"2016","unstructured":"Kaplan YC, Ozsarfati J, Nickel C et al (2016) Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta -analysis [J]. Br J Clin Pharmacol 81(5):835\u2013848","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"6462_CR36","doi-asserted-by":"publisher","first-page":"290 e1","DOI":"10.1016\/j.ajog.2020.09.007","volume":"224","author":"KF Huybrechts","year":"2021","unstructured":"Huybrechts KF, Bateman BT, Zhu Y et al (2021) Hydroxychloroquine early in pregnancy and risk of birth defects[J]. Am J Obstet Gynecol 224(3):290 e1-290 e22","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"6462_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA et al (2019) The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 145(1):1\u201333","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"6462_CR38","first-page":"5","volume":"46","author":"Zhang Yanhong","year":"2019","unstructured":"Yanhong Zhang, Li J, Jing Su et al (2019) Aspirin resistance and genetic polymorphism correlation in pregnant women at high risk of preeclampsia[J]. Intl J Obstet Gynecol 46(4):5","journal-title":"Intl J Obstet Gynecol"},{"issue":"5","key":"6462_CR39","first-page":"4","volume":"37","author":"YD He","year":"2021","unstructured":"He YD, Chen Q (2021) Limitations and clinical application options of aspirin for the prevention of preeclampsia[J]. Chin J Pract Gynecol Obstet 37(5):4","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"5","key":"6462_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/uog.15789","volume":"47","author":"S Roberge","year":"2016","unstructured":"Roberge S, Demers S, Nicolaides KH, Bureau M, C\u00f4t\u00e9 S, Bujold E (2016) Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis. Ultrasound Obstet Gynecol 47(5):548\u2013553","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"6462_CR41","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","volume":"31","author":"JP Buyon","year":"1998","unstructured":"Buyon JP, Hiebert R, Copel J et al (1998) Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a National Neonatal Lupus Registry[J]. J Am Coll Cardiol 31(7):1658","journal-title":"J Am Coll Cardiol"},{"key":"6462_CR42","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bpobgyn.2019.01.002","volume":"58","author":"JS Carvalho","year":"2019","unstructured":"Carvalho JS (2019) Fetal dysrhythmias[J]. Best Pract Res Clin Obstet Gynaecol 58:28\u201341","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"6462_CR43","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","volume":"12","author":"N Gleicher","year":"2013","unstructured":"Gleicher N, Elkayam U (2013) Preventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: a review of published literature and registered clinical trials [J]. Autoimmun Rev 12(11):1039\u20131045","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6462_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","volume":"126","author":"PM Izmirly","year":"2012","unstructured":"Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus[J]. Circulation 126(1):76\u201382","journal-title":"Circulation"},{"issue":"3","key":"6462_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","volume":"76","author":"P Izmirly","year":"2020","unstructured":"Izmirly P, Kim M, Friedman DM et al (2020) Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers[J]. J Am Coll Cardiol 76(3):292\u2013302","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6462_CR46","first-page":"CD012852","volume":"5","author":"EN Hamuly\u00e1k","year":"2020","unstructured":"Hamuly\u00e1k EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S (2020) Aspirin or heparin or both for improving pregnancy outcomes in women with persistent anti-phospholipid antibodies and recurrent pregnancy loss[J]. Cochrane Database Syst Rev 5(5):CD012852","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06462-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06462-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T23:31:23Z","timestamp":1679873483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06462-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["6462"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06462-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee and Institutional Review Board of the Third Hospital of Peking University, People\u2019s Republic of China (2022 No. 203\u201301).This study is a retrospective study, the records and data did not include potential patient identifying information, and the project did not involve any commercial interests. Therefore, an exemption from informed consent of this study was approved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}